SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anthony April Kaye Bullock – ‘4’ for 3/6/20 re: Encompass Health Corp.

On:  Monday, 8/31/20, at 8:54am ET   ·   For:  3/6/20   ·   Accession #:  1127602-20-24412   ·   File #:  1-10315

Previous ‘4’:  ‘4’ on 5/15/20 for 5/14/20   ·   Next:  ‘4’ on 2/23/21 for 2/20/21   ·   Latest:  ‘4’ on 4/25/24 for 4/23/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/31/20  Anthony April Kaye Bullock        4                      1:6K   Encompass Health Corp.            Restricted Stock Sy… Inc

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      3K 
                Securities by an Insider -- form4.xml/3.6                        




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Anthony April Kaye Bullock

(Last)(First)(Middle)
3606 PRINCETON AVENUE

(Street)
DALLASTX75205

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
XOfficer (give title below) Other (specify below)
CEO & President, Home Health
3. Date of Earliest Transaction (Month/Day/Year)
3/6/20
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock 3/6/20 A (1) 548,842A$82.56 (1)548,842IBy HCHB Consulting, Inc.
Encompass Health Common Stock 191,740D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1)  This transaction, described further below, was previously disclosed by Encompass Health Corporation ("EHC") on its Form 8-K, Item 8.01, filed with the Securities and Exchange Commission ("SEC") on February 21, 2020; its Quarterly Report on Form 10-Q, Part II, Item 2, for the quarter ended March 31, 2020; and its Definitive Proxy Statement filed with the SEC on March 27, 2020. On February 20, 2020, EHC entered into an exchange agreement with Ms. Anthony, pursuant to which she had the right to exchange all of her remaining shares of the common stock of Encompass Health Home Health Holdings, Inc. ("Home Health Holdings"), a subsidiary of EHC, valued at approximately $45 million, for shares of common stock of EHC by delivering an exchange notice. Her exchange agreement provided that the number of EHC shares to be delivered equaled the fair value of the shares of Home Health Holdings stock on the date of the exchange agreement, divided by the last reported sales price of EHC common stock on the date of delivery of an exchange notice. On February 20, 2020, EHC also received the exchange notice from Ms. Anthony, on which date the closing price of EHC's common stock was $82.56 per share. Pursuant to the terms of the exchange agreement, on March 6, 2020, EHC delivered 548,842 shares of EHC common stock to Ms. Anthony in exchange for all of her Home Health Holdings stock.
/s/ Patick Darby, attorney-in-fact for April Anthony 8/28/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    A    Grant, award or other acquisition pursuant to Rule 16b-3(d).

Top
Filing Submission 0001127602-20-024412   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 6:27:06.2pm ET